The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine

被引：1
|
作者：
Naughton, M. [1 ]
Allen, A. P. [1 ,2 ]
Clarke, G. [1 ,2 ]
Dowling, J. [3 ]
Walsh, A. [3 ]
Ismail, F. [1 ]
Shorten, G. [3 ]
Scott, L. [1 ]
Cryan, J. F. [2 ,4 ]
Dinan, T. G. [1 ,2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland
[4] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70639-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.b.038
引用
收藏
页码：S401 / S401
页数：1
相关论文
共 50 条
  • [31] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [32] Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
    Kiraly, D. D.
    Horn, S. R.
    Van Dam, N. T.
    Costi, S.
    Schwartz, J.
    Kim-Schulze, S.
    Patel, M.
    Hodes, G. E.
    Russo, S. J.
    Merad, M.
    Iosifescu, D. V.
    Charney, D. S.
    Murrough, J. W.
    TRANSLATIONAL PSYCHIATRY, 2017, 7 : e1065 - e1065
  • [33] Features of Dissociation Differentially Predict Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Niciu, Mark
    Shovestul, Bridget
    Jaso, Brittany
    Farmer, Cristan
    Luckenbaugh, David
    Park, Lawrence
    Ballard, Elizabeth
    Zarate, Carlos
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S564 - S564
  • [34] Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Cornwell, Brian R.
    Salvadore, Giacomo
    Furey, Maura
    Marquardt, Craig A.
    Brutsche, Nancy E.
    Grillon, Christian
    Zarate, Carlos A., Jr.
    BIOLOGICAL PSYCHIATRY, 2012, 72 (07) : 555 - 561
  • [35] Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
    Park, Minkyung
    Newman, Laura E.
    Gold, Philip W.
    Luckenbaugh, David A.
    Yuan, Peixiong
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 84 : 113 - 118
  • [36] Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
    Haile, C. N.
    Murrough, J. W.
    Iosifescu, D. V.
    Chang, L. C.
    Al Jurdi, R. K.
    Foulkes, A.
    Iqbal, S.
    Mahoney, J. J., III
    De La Garza, R., II
    Charney, D. S.
    Newton, T. F.
    Mathew, S. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (02): : 331 - 336
  • [37] Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression
    de la Salle, Sara
    Phillips, Jennifer L.
    Blier, Pierre
    Knott, Verner
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 115
  • [38] Dissociative symptoms predict antidepressant response after infusion of ketamine in treatment-resistant depression
    Echegaray, M. V. F.
    Mello, R.
    Correia-Melo, F. S.
    Leal, G. C.
    Jesus-Nunes, A. P.
    Vieira, F.
    Fontes, A. T. C.
    Beanes, G.
    Magnavita, G.
    Bandeira, I. D.
    Lacerda, A. L. T.
    Quarantini, L. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S321 - S322
  • [39] REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
    Kheirkhah, Mina
    Duncan Jr, Wallace C.
    Yuan, Qiaoping
    Wang, Philip R.
    Jamalabadi, Hamidreza
    Leistritz, Lutz
    Walter, Martin
    Goldman, David
    Zarate, Carlos A.
    Hejazi, Nadia S.
    NEUROPSYCHOPHARMACOLOGY, 2025,
  • [40] Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study
    Berner, Jon
    Acharjee, Animesh
    DISCOVER MENTAL HEALTH, 2024, 4 (01):
12345